Mereo Biopharma Group PLC
NASDAQ:MREO
Mereo Biopharma Group PLC
PP&E Net
Mereo Biopharma Group PLC
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mereo Biopharma Group PLC
NASDAQ:MREO
|
PP&E Net
£1.8m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
PP&E Net
$13m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
PP&E Net
$95.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
PP&E Net
$24.8m
|
CAGR 3-Years
58%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
PP&E Net
£42.7m
|
CAGR 3-Years
5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
PP&E Net
£509.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
See Also
What is Mereo Biopharma Group PLC's PP&E Net?
PP&E Net
1.8m
GBP
Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's PP&E Net amounts to 1.8m GBP.
What is Mereo Biopharma Group PLC's PP&E Net growth rate?
PP&E Net CAGR 3Y
-46%
Over the last year, the PP&E Net growth was -28%. The average annual PP&E Net growth rates for Mereo Biopharma Group PLC have been -46% over the past three years .